An editorial by Fyodor Urnov lays out the urgent case for major reform in the regulatory appraisal of clinical therapies involving CRISPR gene therapies.

Four decades of pioneering medical achievement have positioned the Stem Cell Centre as one of the largest globally for bone ...

You'd think vehicles like the Ford E-series and and Mitsubishi Outlander Sport would have died by now, but they're still ...

Verticals that will be most impacted by innovative developments in technology and science are the disciplines of medicine, ...

Type 2 diabetes affects around one in 15 of the world's population The post People with diabetes who stick to this diet could ...

According to a felony complaint from the Monroe County Sheriff’s Office, Jamie Jo Busch, 53, strangled her sister Penny Busch to death between 4:40 p.m. and 11:59 p.m. on October 8 in her home on ...

Breast cancer is the number one cancer among women: more than 2 million cases were diagnosed worldwide in 2022. It is also ...

By Stephen Beech via SWNS The first consumer product made in Britain using a revolutionary new biotech process that reduces ...

You might think of a landline as a dusty antique of the past made obsolete by cell phones and their easy portability. But for ...

Enzymes help speed up chemical reactions in the body. They control everything from digesting food, to muscle growth, to blood ...

Editas, one of the oldest CRISPR-focused biotechs, is pivoting again — to a sickle cell treatment that requires editing a ...

A research team, affiliated with UNIST has developed nanoparticles that effectively treat acute myeloid leukemia (AML), ...